By considering the comprehensive neuropsychiatric services offered by Sterling Institute, people with bipolar disorder can get tailored care that includes innovative pharmacological interventions like GLP-1 agonists
The SELECT trial, published in The Lancet (October 22, 2025), provides a landmark analysis confirming that the cardioprotective benefits of semaglutide extend beyond weight loss alone. The SELECT Trial: Study Overview The SELECT trial (NCT03574597) enrolled 17,604 participants aged 45 years and above across 41 countries and 804 sites
The starting price for tirzepatide through MEDVi is $279
Enriched with a vitamin complex (including Vitamin C and E), it nourishes and revitalizes the skin, leaving it smooth, radiant, and refreshed
In 2020, it became the only diabetic drug to be approved for reducing or preventing the risk of major cardiovascular events (MACE) in patients with type 2 diabetes
Endocrinology 140: 1132-1140, 1999